Apolipoprotein A-1 Mimetic Peptide 4F Promotes Endothelial Repairing and Compromises Reendothelialization Impaired by Oxidized HDL Through SR-B1

Overview

Journal Redox Biol

Specialties Biology
Cell Biology
Endocrinology

Date 2017 Dec 26

PMID 29277016

Citations 21

Authors

Dan He

Mingming Zhao

Congying Wu

Wenjing Zhang

Chenguang Niu

Baoqi Yu

Jingru Jin

Liang Ji

Belinda Willard

Anna V Mathew

Y Eugene Chen

Subramaniam Pennathur

Huiyong Yin

Yuan He

Bing Pan

Lemin Zheng

Affiliations

Soon will be listed here.

Abstract

Disruption of endothelial monolayer integrity is the primary instigating factor for many cardiovascular diseases. High density lipoprotein (HDL) oxidized by heme enzyme myeloperoxidase (MPO) is dysfunctional in promoting endothelial repair. Apolipoprotein A-1 mimetic 4F with its pleiotropic benefits has been proven effective in many in vivo models. In this study we investigated whether 4F promotes endothelial repair and restores the impaired function of oxidized HDL (Cl/NO-HDL) in promoting re-endothelialization. We demonstrate that 4F and Cl/NO-HDL act on scavenger receptor type I (SR-B1) using human aorta endothelial cells (HAEC) and SR-B1 mouse aortic endothelial cells. Wound healing, transwell migration, lamellipodia formation and single cell migration assay experiments show that 4F treatment is associated with a recovery of endothelial cell migration and associated with significantly increased endothelial nitric oxide synthase (eNOS) activity, Akt phosphorylation and SR-B1 expression. 4F increases NO generation and diminishes oxidative stress. In vivo, 4F can stimulate cell proliferation and re-endothelialization in the carotid artery after treatment with Cl/NO-HDL in a carotid artery electric injury model but fails to do so in SR-B1 mice. These findings demonstrate that 4F promotes endothelial cell migration and has a potential therapeutic benefit against early endothelial injury in cardiovascular diseases.

Citing Articles

Apolipoprotein A-I: Potential Protection Against Intestinal Injury Induced by Dietary Lipid.

Wang J, Yu S, Huang G, Yu Y, Li Y J Inflamm Res. 2024; 17:5711-5721.

PMID: 39219814 PMC: 11366247. DOI: 10.2147/JIR.S468842.

Atheroprotective role of vinpocetine: an old drug with new indication.

Abu-Alghayth M, Al-Kuraishy H, Al-Gareeb A, Alexiou A, Papadakis M, Bahaa M Inflammopharmacology. 2024; 32(6):3669-3678.

PMID: 39141151 PMC: 11550280. DOI: 10.1007/s10787-024-01529-5.

Increased thyroid stimulating hormone (TSH) as a possible risk factor for atherosclerosis in subclinical hypothyroidism.

Alomair B, Al-Kuraishy H, Al-Gareeb A, Alshammari M, Alexiou A, Papadakis M Thyroid Res. 2024; 17(1):13.

PMID: 38880884 PMC: 11181570. DOI: 10.1186/s13044-024-00199-3.

The anti-inflammatory properties of vinpocetine mediates its therapeutic potential in management of atherosclerosis.

Alshehri A, Al-Kuraishy H, Al-Gareeb A, Jawad S, Khawagi W, Alexiou A J Inflamm (Lond). 2024; 21(1):19.

PMID: 38858751 PMC: 11165849. DOI: 10.1186/s12950-024-00394-x.

Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice.

Sun H, Ni Z, Liu Y, Fu X, Liu S, Hu J Cardiovasc Diabetol. 2024; 23(1):138.

PMID: 38664801 PMC: 11046792. DOI: 10.1186/s12933-024-02239-6.

References

Kontush A, Chapman M . Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol. 2010; 21(4):312-8. DOI: 10.1097/MOL.0b013e32833bcdc1. View

Navab M, Anantharamaiah G, Reddy S, Hama S, Hough G, Grijalva V . Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation. 2004; 109(25):3215-20. DOI: 10.1161/01.CIR.0000134275.90823.87. View

Gordon T, CASTELLI W, Hjortland M, Kannel W, DAWBER T . High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977; 62(5):707-14. DOI: 10.1016/0002-9343(77)90874-9. View

Navab M, Anantharamaiah G, Hama S, Garber D, Chaddha M, Hough G . Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 2002; 105(3):290-2. DOI: 10.1161/hc0302.103711. View

Smythies L, White C, Maheshwari A, Palgunachari M, Anantharamaiah G, Chaddha M . Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. Am J Physiol Cell Physiol. 2010; 298(6):C1538-48. PMC: 2889631. DOI: 10.1152/ajpcell.00467.2009. View

Huang Y, Wu Z, Riwanto M, Gao S, Levison B, Gu X . Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest. 2013; 123(9):3815-28. PMC: 3754253. DOI: 10.1172/JCI67478. View

Sharma S, Umar S, Potus F, Iorga A, Wong G, Meriwether D . Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p. Circulation. 2014; 130(9):776-85. PMC: 4194270. DOI: 10.1161/CIRCULATIONAHA.114.007405. View

Liu J, Yao S, Wang S, Jiao P, Song G, Yu Y . D-4F, an apolipoprotein A-I mimetic peptide, protects human umbilical vein endothelial cells from oxidized low-density lipoprotein-induced injury by preventing the downregulation of pigment epithelium-derived factor expression. J Cardiovasc Pharmacol. 2014; 63(6):553-61. DOI: 10.1097/FJC.0000000000000080. View

Giannotti G, Doerries C, Mocharla P, Mueller M, Bahlmann F, Horvath T . Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension. 2010; 55(6):1389-97. DOI: 10.1161/HYPERTENSIONAHA.109.141614. View

10.

Miura S, Fujino M, Matsuo Y, Kawamura A, Tanigawa H, Nishikawa H . High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. 2003; 23(5):802-8. DOI: 10.1161/01.ATV.0000066134.79956.58. View

11.

Zhu W, Saddar S, Seetharam D, Chambliss K, Longoria C, Silver D . The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res. 2008; 102(4):480-7. DOI: 10.1161/CIRCRESAHA.107.159079. View

12.

Datta G, Chaddha M, Hama S, Navab M, Fogelman A, Garber D . Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J Lipid Res. 2001; 42(7):1096-104. View

13.

Navab M, Anantharamaiah G, Reddy S, Van Lenten B, Wagner A, Hama S . An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2005; 25(9):1932-7. DOI: 10.1161/01.ATV.0000174589.70190.e2. View

14.

Pan B, Ma Y, Ren H, He Y, Wang Y, Lv X . Diabetic HDL is dysfunctional in stimulating endothelial cell migration and proliferation due to down regulation of SR-BI expression. PLoS One. 2012; 7(11):e48530. PMC: 3487724. DOI: 10.1371/journal.pone.0048530. View

15.

He D, Pan B, Ren H, Zheng L . Effects of diabetic HDL on endothelial cell function. Cardiovasc Hematol Disord Drug Targets. 2014; 14(2):137-41. DOI: 10.2174/1871529x14666140505124415. View

16.

Shao B, Bergt C, Fu X, Green P, Voss J, Oda M . Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem. 2004; 280(7):5983-93. DOI: 10.1074/jbc.M411484200. View

17.

Wu C, Asokan S, Berginski M, Haynes E, Sharpless N, Griffith J . Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis. Cell. 2012; 148(5):973-87. PMC: 3707508. DOI: 10.1016/j.cell.2011.12.034. View

18.

Choudhury R, Rong J, Trogan E, Elmalem V, Dansky H, Breslow J . High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation. Arterioscler Thromb Vasc Biol. 2004; 24(10):1904-9. DOI: 10.1161/01.ATV.0000142808.34602.25. View

19.

Hall B, Armitage J, Sansom M . Transmembrane helix dynamics of bacterial chemoreceptors supports a piston model of signalling. PLoS Comput Biol. 2011; 7(10):e1002204. PMC: 3197627. DOI: 10.1371/journal.pcbi.1002204. View

20.

Imaizumi S, Navab M, Morgantini C, Charles-Schoeman C, Su F, Gao F . Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. Circ J. 2011; 75(7):1533-8. PMC: 3625624. DOI: 10.1253/circj.cj-11-0460. View